Interestingly, our primary tumor growth results were similar to results by Jiang and colleagues, who used implanted human PDAC cells (BxPC-3 and PANC-1) into immunocompromised mice after shRNA knockdown of Bmal1 [20,21]. Here, BMAL1 is linked to neoplasm.